First-trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects

Ultrasound in Obstetrics and Gynecology

Volumn 36, Issue 6, 2010, Pages 668-675

  Timmerman, E ^a   Clur, S A ^b,c   Pajkrt, E ^a   Bilardo, C M ^a,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c Center for Congenital Heart Defects Amsterdam Leiden (CAHAL)   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cardiac function; congenital heart defect; ductus venosus; first trimester screening; nuchal translucency

Indexed keywords

ARTICLE; BLOOD FLOW VELOCITY; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; FETUS HEART; FIRST TRIMESTER PREGNANCY; GENETICS; HUMAN; METHODOLOGY; NUCHAL TRANSLUCENCY MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PREGNANCY; STATISTICAL MODEL; UMBILICAL VEIN; VASCULARIZATION;

BLOOD FLOW VELOCITY; FEMALE; FETAL HEART; HEART DEFECTS, CONGENITAL; HUMANS; LOGISTIC MODELS; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; ULTRASONOGRAPHY, PRENATAL; UMBILICAL VEINS;

EID: 78649669558     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.7742     Document Type: Article

References (47)

1. Tegnander E, Williams W, Johansen OJ, Blaas HG, Eik-Nes SH,. Prenatal detection of heart defects in a non-selected population of 30149 fetuses-detection rates and outcome. Ultrasound Obstet.Gynecol 2006; 27: 252-265.
2. McBrien A, Sands A, Craig B, Dornan J, Casey F,. Major congenital heart disease: antenatal detection, patient characteristics and outcomes. J Matern Fetal Neonatal Med 2009; 22: 101-105.
3. Clur SA, Ottenkamp J, Bilardo CM,. The nuchal translucency and the fetal heart: a literature review. Prenat Diagn 2009; 29: 739-748.
4. Becker R, Wegner RD,. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan. Ultrasound Obstet Gynecol 2006; 27: 613-618.
5. Carvalho JS,. Fetal heart scanning in the first trimester. Prenat Diagn 2004; 24: 1060-1067.
6. Hyett J,. Does nuchal translucency have a role in fetal cardiac screening? Prenat Diagn 2004; 24: 1130-1135.
7. Ghi T, Huggon IC, Zosmer N, Nicolaides KH,. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001; 18: 610-614.
8. Makrydimas G, Sotiriadis A, Huggon IC, Simpson J, Sharland G, Carvalho JS, Daubeney PE, Ioannidis JP,. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005; 192: 89-95.
9. Bilardo CM, Muller MA, Zikulnig L, Schipper M, Hecher K,. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001; 17: 288-294.
10. Oh C, Harman C, Baschat AA,. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency. Ultrasound Obstet Gynecol 2007; 30: 192-196.
11. Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH,. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13 + 6 weeks of gestation. Obstet Gynecol 2008; 112: 598-605.
12. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH,. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307-310.
13. Montenegro N, Matias A, Areias JC, Barros H,. Ductus venosus revisited: a Doppler blood flow evaluation in the first trimester of pregnancy. Ultrasound Med Biol 1997; 23: 171-176.
14. Favre R, Cherif Y, Kohler M, Kohler A, Hunsinger MC, Bouffet N, Tanghe M, Cancellier M, Nisand I,. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol 2003; 21: 239-243.
15. Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K,. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2008; 31: 256-260.
16. Haak MC, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM,. Ductus venosus flow velocities in relation to the cardiac defects in first-trimester fetuses with enlarged nuchal translucency. Am J Obstet Gynecol 2003; 188: 727-733.
17. Borrell A,. The ductus venosus in early pregnancy and congenital anomalies. Prenat Diagn 2004; 24: 688-692.
18. The Fetal Medicine Foundation. [Accessed 27 October 2009].
19. Teixeira LS, Leite J, Viegas MJ, Faria MM, Chaves AS, Teixeira RC, Pires MC, Pettersen H,. Ductus venosus Doppler velocimetry in the first trimester: a new finding. Ultrasound Obstet Gynecol 2008; 31: 261-265.
20. Altman DG, Royston P,. What do we mean by validating a prognostic model? Stat Med 2000; 19: 453-473.
21. Vogel M, Sharland GK, McElhinney DB, Zidere V, Simpson JM, Miller OI, Allan LD,. Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotype. Cardiol Young 2009; 19: 441-445.
22. Berg C, Kremer C, Geipel A, Kohl T, Germer U, Gembruch U,. Ductus venosus blood flow alterations in fetuses with obstructive lesions of the right heart. Ultrasound Obstet Gynecol 2006; 28: 137-142.
23. Hung JH, Fu CY, Lu JH, Hung CY,. Ductus venosus blood flow resistance and congenital heart defects in the second trimester. J Clin Ultrasound 2008; 36: 72-78.
24. Martínez JM, Comas M, Borrell A, Bennasar M, Gómez O, Puerto B, Gratacós E,. Abnormal first trimester ductus venosus: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency. Ultrasound Obstet Gynecol 2010; 35: 267-272.
25. Huisman TW, Bilardo CM,. Transient increase in nuchal translucency thickness and reversed end-diastolic ductus venosus flow in a fetus with trisomy 18. Ultrasound Obstet Gynecol 1997; 10: 397-399.
26. Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH,. Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks' gestation. Ultrasound Obstet Gynecol 2008; 31: 503-506.
27. Borrell A, Perez M, Figueras F, Meler E, Gonce A, Gratacos E,. Reliability analysis on ductus venosus assessment at 11-14 weeks' gestation in a high-risk population. Prenat Diagn 2007; 27: 442-446.
28. Mavrides E, Holden D, Bland JM, Tekay A, Thilaganathan B,. Intraobserver and interobserver variability of transabdominal Doppler velocimetry measurements of the fetal ductus venosus between 10 and 14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 17: 306-310.
29. Prefumo F, Risso D, Venturini PL, De Biasio P,. Reference values for ductus venosus Doppler flow measurements at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 2002; 20: 42-46.
30. Kiserud T, Eik-Nes SH, Hellevik LR, Blaas H-G,. Ductus venosus-A longitudinal doppler velocimetric study of the human fetus. J Matern Fetal Invest 1992; 2: 5-11.
31. Diemert A, Hecher K,. Severely abnormal flow patterns in the ductus venosus in the presence of otherwise normal fetal Doppler parameters in two cases of severe intrauterine growth restriction. Ultrasound Obstet Gynecol 2009; 34: 605-607.
32. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O,. Multicenter study of first- trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226.
33. Timmerman E, Oude Rengerink K, Pajkrt E, Opmeer BC, Van der Post JAM, Bilardo CM,. Ductus venosus pulsatility index measurement reduces the false-positive rate in first-trimester screening. Ultrasound Obstet Gynecol 2010; 36: 661-667.
34. Antolin E, Comas C, Torrents M, Munoz A, Figueras F, Echevarria M, Cararach M, Carrera JM,. The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. Ultrasound Obstet Gynecol 2001; 17: 295-300.
35. Hecher K,. Assessment of ductus venosus flow during the first and early second trimesters: what can we expect? Ultrasound Obstet Gynecol 2001; 17: 285-287.
36. Matias A, Montenegro N,. Ductus venosus blood flow in chromosomally abnormal fetuses at 11 to 14 weeks of gestation. Semin Perinatol 2001; 25: 32-37.
37. Toyama JM, Brizot ML, Liao AW, Lopes LM, Nomura RM, Saldanha FA, Zugaib M,. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome. Ultrasound Obstet Gynecol 2004; 23: 341-345.
38. Bilardo CM, Timmerman E, Pajkrt E, Van Maarle MC,. Increased nuchal translucency in euploid fetuses-what should we be telling the parents? Prenat Diagn 2010; 30: 93-102.
39. Allan LD,. The mystery of nuchal translucency. Cardiol Young 2006; 16: 11-17.
40. Gembruch U, Meise C, Germer U, Berg C, Geipel A,. Venous Doppler ultrasound in 146 fetuses with congenital heart disease. Ultrasound Obstet Gynecol 2003; 22: 345-350.
41. Murta CG, Moron AF, Avila MA, Weiner CP,. Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy. Fetal Diagn Ther 2002; 17: 308-314.
42. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH,. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Ultrasound Obstet Gynecol 2005; 26: 22-27.
43. Huggon IC, Turan O, Allan LD,. Doppler assessment of cardiac function at 11-14 weeks' gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol 2004; 24: 390-398.
44. Clur SA, Oude Rengerink K, Mol BWJ, Ottencamp J, Bilardo CM,. Fetal cardiac function between 11 and 35 weeks' gestation and nuchal translucency thickness. Ultrasound Obstet Gynecol 2010; DOI:10.1002/uog.8807.
45. Coceani F, Adeagbo AS, Cutz E, Olley PM,. Autonomic mechanisms in the ductus venosus of the lamb. Am J Physiol 1984; 247: H17-H24.
46. Nakamura T, Gulick J, Colbert MC, Robbins J,. Protein tyrosine phosphatase activity in the neural crest is essential for normal heart and skull development. Proc Natl Acad Sci USA 2009; 106: 11270-11275.
47. Bekker MN, Arkesteijn JB, Van Den Akker NM, Hoffman S, Webb S, Van Vugt JM, Gittenberger-De Groot AC,. Increased NCAM expression and vascular development in Trisomy 16 mouse embryos: relationship with nuchal translucency. Pediatr Res 2005; 58: 1222-1227.